These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7547647)

  • 1. Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis.
    Salokangas RK
    Schizophr Res; 1995 Jul; 16(1):7-16. PubMed ID: 7547647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender and the use of neuroleptics in schizophrenia.
    Salokangas RK
    Schizophr Res; 2004 Jan; 66(1):41-9. PubMed ID: 14693351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of smoking on neuroleptics in schizophrenia.
    Salokangas RK; Saarijärvi S; Taiminen T; Lehto H; Niemi H; Ahola V; Syvälahti E
    Schizophr Res; 1997 Jan; 23(1):55-60. PubMed ID: 9050128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance.
    Meltzer HY; Rabinowitz J; Lee MA; Cola PA; Ranjan R; Findling RL; Thompson PA
    Am J Psychiatry; 1997 Apr; 154(4):475-82. PubMed ID: 9090333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
    Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
    Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paranoid/belligerence and neuroleptic dosage in newly admitted schizophrenic patients.
    Troisi A; Pasini A; de Angelis F; Spalletta G
    J Clin Psychopharmacol; 1997 Apr; 17(2):84-7. PubMed ID: 10950468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic and anticholinergic drug use in Chinese patients with schizophrenia resident in a state psychiatric hospital in Singapore.
    Chong SA; Sachdev P; Mahendran R; Chua HC
    Aust N Z J Psychiatry; 2000 Dec; 34(6):988-91. PubMed ID: 11127630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phases of the menstrual cycle and therapeutic response to neuroleptic therapy in patients with schizophrenia].
    Vanurová I; Yamamotová A
    Cas Lek Cesk; 2001 Oct; 140(21):668-70. PubMed ID: 11766456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden.
    Kiivet RA; Llerena A; Dahl ML; Rootslane L; Sánchez Vega J; Eklundh T; Sjöqvist F
    Br J Clin Pharmacol; 1995 Nov; 40(5):467-76. PubMed ID: 8703651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in schizophrenia.
    Häfner H
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():17-54. PubMed ID: 12650680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age at onset of schizophrenia and neuroleptic dosage.
    Dernovsek MZ; Tavcar R
    Soc Psychiatry Psychiatr Epidemiol; 1999 Dec; 34(12):622-6. PubMed ID: 10703271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-resistant schizophrenia--the role of clozapine.
    Meltzer HY
    Curr Med Res Opin; 1997; 14(1):1-20. PubMed ID: 9524789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ERPs changes during neuroleptic treatment in schizophrenia--a vulnerability marker in schizophrenia].
    Asato N; Hirayasu Y; Hiramatsu K; Ohta H
    Seishin Shinkeigaku Zasshi; 1999; 101(3):254-76. PubMed ID: 10375977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenics fully remitted on neuroleptics for 3-5 years--to stop or continue drugs?
    Cheung HK
    Br J Psychiatry; 1981 Jun; 138():490-4. PubMed ID: 6117347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-related clinical differences in older patients with schizophrenia.
    Lindamer LA; Lohr JB; Harris MJ; McAdams LA; Jeste DV
    J Clin Psychiatry; 1999 Jan; 60(1):61-7; quiz 68-9. PubMed ID: 10074884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic drug utilisation for acute schizophrenia.
    Razali MS; Hasanah CI
    Singapore Med J; 1996 Dec; 37(6):611-3. PubMed ID: 9104062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic nonresponse and affective symptoms: a 2-year prospective study of schizophrenic outpatients.
    Faraone SV; Young AS; Brown WA
    Psychiatry Res; 1989 Jun; 28(3):315-21. PubMed ID: 2569751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects.
    Gupta S; Andreasen NC; Arndt S; Flaum M; Schultz SK; Hubbard WC; Smith M
    Am J Psychiatry; 1995 Feb; 152(2):191-6. PubMed ID: 7840351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.